Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Share-based Compensation (2010 - 2026)

Omeros (OMER) posted Share-based Compensation of $1.9 million for Q1 2026, up 9.0% sequentially from $1.7 million in Q4 2025, and down 22.99% YoY from $2.5 million in Q1 2025.

Analysis

Omeros (OMER) Share-based Compensation (2010 - 2026) Analysis & Trends

Omeros has reported Share-based Compensation for 17 years, with the latest figure at $1.9 million in Q1 2026.

  • Quarterly Share-based Compensation fell 22.99% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (down 14.37% YoY) and the FY2025 annual result came in at $12.1 million, down 3.2% from the prior year.
  • Share-based Compensation rose to $1.9 million in Q1 2026 per OMER's latest filing, from $1.7 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $3.9 million in Q1 2022 and troughed at $856000.0 in Q3 2025.
  • A 5-year average of $2.5 million and a median of $2.7 million in 2024 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2024 and 2025: Share-based Compensation slumped 67.14% in 2024, then climbed 21.54% in 2025.
  • Over 5 years, Share-based Compensation stood at $3.3 million in 2022, then dropped by 17.56% to $2.7 million in 2023, then decreased by 9.85% to $2.4 million in 2024, then declined by 28.57% to $1.7 million in 2025, then increased by 9.0% to $1.9 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $1.9 million, $1.7 million, and $856000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 16.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.22 Mn
Mar 31, 2026 17.21 Mn
Dec 31, 2025 1.73 Mn
Sep 30, 2025 19.50 Mn
Jun 30, 2025 19.72 Mn
Mar 31, 2025 16.64 Mn
Dec 31, 2024 2.43 Mn
Sep 30, 2024 18.13 Mn
Jun 30, 2024 17.99 Mn
Mar 31, 2024 15.15 Mn
Dec 31, 2023 2.69 Mn
Sep 30, 2023 15.30 Mn
Jun 30, 2023 13.62 Mn
Mar 31, 2023 13.72 Mn
Dec 31, 2022 3.26 Mn
Sep 30, 2022 14.67 Mn
Jun 30, 2022 12.37 Mn
Mar 31, 2022 12.44 Mn
Dec 31, 2021 5.55 Mn
Sep 30, 2021 13.24 Mn